tradingkey.logo
tradingkey.logo
Search

Alzamend Neuro Inc

ALZN
Add to Watchlist
1.310USD
-0.040-2.96%
Close 07-31 16:00ETQuotes delayed by 15 min
113.35KMarket Cap
LossP/E TTM

ALZN Financials

See Alzamend Neuro Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Alzamend Neuro Inc Earnings Date

Latest Release
Jul 22, 2026
EPS / Forecast
-2.63/--
Revenue / Forecast
--/--
Period
FY2026 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.63
97.42%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Financial Indicators
EPS
70.36%-0.72
65.91%-0.58
91.79%-0.30
88.62%-1.28
78.16%-2.43
95.01%-1.70
90.95%-3.61
76.70%-11.27
75.85%-11.14
54.40%-33.97
7.47%-39.85
---48.38
---46.12
---74.49
---43.06
---4.67
----
----
----
----
Net Profit
-65.92%-2.87M
-111.56%-2.20M
29.29%-1.00M
-177.37%-2.70M
-103.13%-1.73M
60.96%-1.04M
51.30%-1.42M
72.38%-974.41K
74.24%-851.53K
50.93%-2.66M
6.56%-2.91M
-16.16%-3.53M
14.57%-3.31M
-110.88%-5.43M
13.61%-3.11M
-30.92%-3.04M
---3.87M
-129.95%-2.57M
---3.60M
---2.32M
Debt to assets ratio
----
----
----
----
-100.00%0.00%
----
----
--0.00%
--47.61%
----
----
----
--0.00%
----
----
--0.00%
----
----
----
----
Operating profit
-152.07%-2.87M
-111.84%-2.20M
26.51%-998.11K
-180.57%-2.70M
-33.98%-1.14M
61.00%-1.04M
53.20%-1.36M
72.70%-962.40K
74.28%-850.06K
50.96%-2.66M
6.59%-2.90M
-16.15%-3.53M
14.66%-3.31M
-112.14%-5.42M
13.32%-3.11M
-31.62%-3.04M
---3.87M
-129.15%-2.56M
---3.58M
---2.31M
Net Profit
-65.92%-2.87M
-111.56%-2.20M
29.29%-1.00M
-177.37%-2.70M
-103.13%-1.73M
60.96%-1.04M
51.30%-1.42M
72.38%-974.41K
74.24%-851.53K
50.93%-2.66M
6.56%-2.91M
-16.16%-3.53M
14.57%-3.31M
-110.88%-5.43M
13.61%-3.11M
-30.92%-3.04M
---3.87M
-129.95%-2.57M
---3.60M
---2.32M
Current assets
-57.76%1.76M
-6.28%3.70M
-0.95%4.72M
318.65%5.93M
817.62%4.18M
564.98%3.95M
509.65%4.77M
-41.32%1.42M
-92.20%455.24K
-92.95%593.61K
-92.43%781.88K
-80.08%2.41M
-59.51%5.84M
-32.28%8.42M
-28.73%10.33M
-27.96%12.11M
--14.41M
1449.75%12.43M
1376.78%14.50M
--16.82M
Total current liabilities
112.07%1.35M
155.88%1.86M
-42.82%717.49K
-65.88%983.31K
-80.32%634.76K
-81.03%725.85K
-65.77%1.25M
5.15%2.88M
12.39%3.23M
44.81%3.83M
123.89%3.67M
166.44%2.74M
146.38%2.87M
465.87%2.64M
10.98%1.64M
-30.18%1.03M
--1.16M
-77.74%466.98K
-10.51%1.48M
--1.47M
Total assets
-54.83%2.08M
-3.20%4.04M
1.68%5.09M
278.88%6.33M
628.80%4.60M
433.53%4.18M
409.12%5.01M
-36.46%1.67M
-89.32%631.59K
-90.79%782.64K
-90.56%983.60K
-78.48%2.63M
-59.25%5.92M
-31.60%8.50M
-28.11%10.42M
-27.39%12.21M
--14.52M
1449.75%12.43M
1376.78%14.50M
--16.82M
Total liabilities
112.07%1.35M
155.88%1.86M
-42.82%717.49K
-65.88%983.31K
-80.32%634.76K
-84.11%725.85K
-65.77%1.25M
5.15%2.88M
12.39%3.23M
72.90%4.57M
123.89%3.67M
166.44%2.74M
146.38%2.87M
465.87%2.64M
10.98%1.64M
-30.18%1.03M
--1.16M
-77.74%466.98K
-10.51%1.48M
--1.47M
Total equity
-81.52%733.21K
-36.68%2.18M
16.55%4.37M
540.76%5.34M
252.97%3.97M
191.12%3.45M
239.91%3.75M
-973.96%-1.21M
-185.18%-2.59M
-164.61%-3.79M
-130.53%-2.68M
-101.01%-112.88K
-77.19%3.05M
-51.02%5.86M
-32.54%8.79M
-27.13%11.18M
--13.35M
1023.04%11.96M
2053.52%13.03M
--15.34M
Net operating income
-306.17%-2.80M
-21.96%-1.74M
65.55%-1.17M
-123.80%-2.36M
51.73%-688.71K
29.93%-1.42M
-124.66%-3.40M
67.99%-1.06M
36.17%-1.43M
-12.43%-2.03M
35.44%-1.51M
-30.02%-3.30M
-43.07%-2.24M
-1.36%-1.81M
-14.57%-2.34M
-107.47%-2.54M
---1.56M
-121.16%-1.78M
---2.05M
---1.22M
Net investment
100.00%0.00
----
--0.00
100.00%0.00
---210.00K
--0.00
--0.00
38.88%-90.00K
--0.00
--0.00
--0.00
---147.24K
----
----
----
----
---106.46K
--0.00
----
----
Net financing
-46.63%794.84K
-100.00%0.00
-100.00%0.00
105.49%4.04M
-2.02%1.49M
-67.43%688.70K
34727.36%6.30M
--1.96M
759844.00%1.52M
--2.11M
--18.09K
----
-99.99%200.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--3.94M
-99.95%400.00
--700.00
--14.91M

FAQs

What are the current assets of Alzamend Neuro Inc?

According to Alzamend Neuro Inc's FY2026 earnings report, its current assets were 1.76M, with a year-on-year change of -57.76.

What are the total assets of Alzamend Neuro Inc?

According to Alzamend Neuro Inc's FY2026 earnings report, its total assets of Alzamend Neuro Inc were 2.08M, with a year-on-year change of -54.83.

What are the total liabilities of Alzamend Neuro Inc?

According to Alzamend Neuro Inc's FY2026 earnings report, its total liabilities of Alzamend Neuro Inc were 1.35M, with a year-on-year change of 112.07.

What is the total equity of Alzamend Neuro Inc?

According to Alzamend Neuro Inc's FY2026 earnings report, its total equity of Alzamend Neuro Inc was 733.21K, with a year-on-year change of -81.52.

What is the net operating income of Alzamend Neuro Inc?

According to Alzamend Neuro Inc's FY2026 earnings report, its net operating income of Alzamend Neuro Inc was -8.77M, with a year-on-year change of -94.96.

What is the net financing of Alzamend Neuro Inc?

According to Alzamend Neuro Inc's FY2026 earnings report, its net financing of Alzamend Neuro Inc was 4.83M, with a year-on-year change of -53.74.

What is the Earnings Per Share (EPS) of Alzamend Neuro Inc?

According to Alzamend Neuro Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -2.63, with a year-on-year change of 97.42.

What is the net income of Alzamend Neuro Inc?

According to Alzamend Neuro Inc's FY2026 earnings report, its net income was -8.77M, with a year-on-year change of -71.84.

What is the Return on Equity (ROE) of Alzamend Neuro Inc?

According to Alzamend Neuro Inc's FY2026 earnings report, its Return on Equity (ROE) was -373.18, with a year-on-year change of 49.78.

What is the Return on Assets (ROA) of Alzamend Neuro Inc?

According to Alzamend Neuro Inc's FY2026 earnings report, its Return on Assets (ROA) was -262.55, with a year-on-year change of -52.20.

What is the operating profit of Alzamend Neuro Inc?

According to Alzamend Neuro Inc's FY2026 earnings report, its operating profit was -8.77M, with a year-on-year change of -94.96.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.